The antigen-binding fragments (Fab) of antibodies are powerful tools in clinical therapy, molecular diagnostics and basic research. However, their principal applications require pure recombinant molecules in large amounts, which are challenging to obtain. Severe limitations in yield, folding and functionality are commonly encountered in bacterial production of Fab fragments. Secretion into the oxidizing periplasm generally results in low yield, whereas expression in the reducing cytoplasmic environment produces unfolded or non-functional protein. We hypothesized that an impaired reducing environment of the cytoplasm would permit correctly folded, functional cytoplasmic expression of Fabs with high yield. We used the Escherichia coli strain ...
Bacterial expression systems can greatly facilitate protein engineering of antibodies. We have devel...
abstract: The C6T single-chain variable fragment (scFv) is an antibody fragment designed as a potent...
The monoclonal antibody market represents the fastest-growing segment within the biopharmaceutical i...
The antigen-binding fragments (Fab) of antibodies are powerful tools in clinical therapy, molecular ...
The antigen-binding fragments (Fab) of antibodies are powerful tools in clinical therapy, molecular ...
An immunoglobulin (IgG) consists of two antigen-binding fragments (Fab) connected to a crystallisabl...
Fab fragments of IgG1 and IgG3 subclass antibodies which bind to 2-phenyloxazolone (Ox) were produce...
Fab fragments of IgG1 and IgG3 subclass antibodies which bind to 2-phenyloxazolone (Ox) were produce...
Antibody engineering and advances in microbial expression systems have enabled production of small, ...
Background: Recombinant proteins, including antibodies and antibody fragments, often contain disulfi...
AbstractThe heavy chain (Hc) and light chain (Lc) genes of the Fab fragment of a catalytic antibody ...
The expression of antibody fragments in bacteria is often hindered by low expression yields and the ...
Antibody fragments are used in the clinic as important therapeutic proteins for treatment of indicat...
Antibody fragments are used in the clinic as important therapeutic proteins for treatment of indicat...
Many attempts have been made to develop antibody fragments that can be expressed in the cytoplasm ("...
Bacterial expression systems can greatly facilitate protein engineering of antibodies. We have devel...
abstract: The C6T single-chain variable fragment (scFv) is an antibody fragment designed as a potent...
The monoclonal antibody market represents the fastest-growing segment within the biopharmaceutical i...
The antigen-binding fragments (Fab) of antibodies are powerful tools in clinical therapy, molecular ...
The antigen-binding fragments (Fab) of antibodies are powerful tools in clinical therapy, molecular ...
An immunoglobulin (IgG) consists of two antigen-binding fragments (Fab) connected to a crystallisabl...
Fab fragments of IgG1 and IgG3 subclass antibodies which bind to 2-phenyloxazolone (Ox) were produce...
Fab fragments of IgG1 and IgG3 subclass antibodies which bind to 2-phenyloxazolone (Ox) were produce...
Antibody engineering and advances in microbial expression systems have enabled production of small, ...
Background: Recombinant proteins, including antibodies and antibody fragments, often contain disulfi...
AbstractThe heavy chain (Hc) and light chain (Lc) genes of the Fab fragment of a catalytic antibody ...
The expression of antibody fragments in bacteria is often hindered by low expression yields and the ...
Antibody fragments are used in the clinic as important therapeutic proteins for treatment of indicat...
Antibody fragments are used in the clinic as important therapeutic proteins for treatment of indicat...
Many attempts have been made to develop antibody fragments that can be expressed in the cytoplasm ("...
Bacterial expression systems can greatly facilitate protein engineering of antibodies. We have devel...
abstract: The C6T single-chain variable fragment (scFv) is an antibody fragment designed as a potent...
The monoclonal antibody market represents the fastest-growing segment within the biopharmaceutical i...